Clinical trial

Indacaterol EfectIveness In COPD Patients With Tuberculosis History

NCT01778062

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhasePHASE3

Study timeline

Study start (unknown)2013-02-01Date precision: month

Registry last updated2015-10-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Patients With Moderate-to-severe COPD With Destroyed Lung by Tuberculosisunresolved

Interventions

IndacaterolDRUG

ControlDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

SeoulSouth Korea4 IncheonSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01778062 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.